通过suzetrigine,LTGO-33和A-88782626进行差异状态依赖的Nav1.8抑制
Sooyeon Jo1, Akie Fujita1, Tomás Osorno1
1Department of Neurobiology, Harvard Medical School, Boston, MA, USA.
The Journal of general physiology
|March 26, 2025
概括
纳维1.8抑制剂A-887826,苏泽特里金和LTGO-33显示出不同的疼痛缓解. 与suzetrigine和LTGO-33不同的是,A-887826在作用电位期间表现出反向的使用依赖,这是由于不同的电压依赖的缓解动力学.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生理学 生理学 生理学
背景情况:
- Nav1.8 通道对于疼痛信号的传递至关重要.
- Nav1.8 抑制剂在疼痛管理方面表现有前途.
- 一些抑制剂表现出由脱极化缓解的状态依赖性抑制.
研究的目的:
- 在生理条件下比较Nav1.8抑制剂的状态依赖作用.
- 调查在动作潜能发射期间的"反向使用依赖性".
- 了解药物动力学如何影响抑制缓解.
主要方法:
- 通过A-887826,suzetrigine和LTGO-33对Nav1.8通道的抑制进行了评估.
- 应用了20 Hz和37°C的动作电位 (AP) 波形.
- 分析了电压依赖性和解离/重新结合动力学.
主要成果:
- 在A-887826抑制被显著缓解APs在20赫兹.
- 苏泽特里金和LTGO-33在AP列车中没有显示任何缓解,尽管缓解具有强烈的去极化.
- 差异归因于电压依赖的缓解和重新结合动力学.
结论:
- A-887826显示了Nav1.8抑制的反向使用依赖的缓解.
- 由于不同的动力性质,苏丁和LTGO-33在生理AP发射过程中缺乏使用依赖的缓解.
- 这些发现突出了对疼痛治疗发展至关重要的不同Nav1.8抑制剂行为.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Antiepileptic Drugs: Potassium Channel Activators
138
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
138
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
199
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
199
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
206
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
206
Ligand-gated Ion Channels
12.1K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.1K
Drugs Affecting Neurotransmitter Release or Uptake
911
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
911


